12435860

Source:http://linkedlifedata.com/resource/pubmed/id/12435860

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0014822, umls-concept:C0087111, umls-concept:C0751956
pubmed:dateCreated	2002-11-18
pubmed:abstractText	Erythropoietin (EPO) and its receptor play a major role in embryonic brain, are weakly expressed in normal postnatal/adult brain and up-regulated upon metabolic stress. EPO protects neurons from hypoxic/ ischemic injury. The objective of this trial is to study the safety and efficacy of recombinant human EPO (rhEPO) for treatment of ischemic stroke in man.
pubmed:language	eng
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Erythropoietin
pubmed:status	MEDLINE
pubmed:author	pubmed-author:BohnMatthiasM, pubmed-author:BreiterNorbertN, pubmed-author:BrinesMichaelM, pubmed-author:CepekLukasL, pubmed-author:CeramiAnthonyA, pubmed-author:De RyckMarcM, pubmed-author:DembowskiChristophC, pubmed-author:EhrenreichHanneloreH, pubmed-author:GefellerOlafO, pubmed-author:GleiterChristophC, pubmed-author:HasselblattMartinM, pubmed-author:ItriLorettaL, pubmed-author:JacobSonjaS, pubmed-author:KnerlichFriederikeF, pubmed-author:KochenMichaelM, pubmed-author:LewczukPiotrP, pubmed-author:PoserWolfgangW, pubmed-author:PrangeHilmarH, pubmed-author:RütherEckartE, pubmed-author:RustenbeckHans-HeinoHH, pubmed-author:SirénAnna-LeenaAL, pubmed-author:StiefelMichaelM, pubmed-author:WesselThomas CTC
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	495-505
pubmed:dateRevised	2008-11-20
pubmed:articleTitle	Erythropoietin therapy for acute stroke is both safe and beneficial.
pubmed:affiliation	Max-Planck-Institute for Experimental Medicine, Departments of Neurology and Psychiatry, Georg-August-University, Goettingen, Germany. ehrenreich@em.mpg.de